The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The yanks might see this moving and start to pile in.
10 per cent swing and it looks like it’s finally turned.
Just purchased 1097 TLSA shares at 81.54p.
News flow has been poor this year but get the feeling this is about to hot up.
Is anyone here buying TLSA at the moment?
Cracking price for the remaining believers.
Haha, I understand the scepticism but let’s see.
I made it clear that I didn’t think it was great that only one person had been dosed this year, trial wise.
She was quite bullish actually in her response and I think the company have been frustrated with the regulatory process, especially in Brazil.
Personally, I think some positive Accustem news is going to be a really big catalyst for TLSA and really start to get things moving.
I think we’ll go from a news weak period to a news rich period.
Spoke to Hana in the office today.
Accustem news before Christmas.
Something must be happening, cash burn is going through the roof!
I don’t think they are fussed! Complete radio silence again now. Couldn’t tell you why….
The swings on the Accustem OTC stock price look violent to me. I’ve not dabbled, I’m at my limit here but I’m guessing there’s a lot of money to be made there for traders.
Exactly Greend, share consolidation is irrelevant here. Investors are obviously frustrated.
I don’t believe it’s a scam. Poorly handled? Yes.
Some good news for either TLSA or Accustem and sentiment will start to turn for both companies.
It’s the equivalent of 0.60p.
Good to see a decent rise. The move to the Nasdaq will prove to be a wise move.
Yep I expect this to move quick when it does move.
You appear to have changed your tune Mr Wong?
Delisting is the correct move but let’s hope we see some action from the BOD in the next few weeks.
What’s been delivered to shareholders this calendar year has been pretty poor to be honest.
The calm before the storm! It will turn!
Another £2000 added at 54.48p for me.
It’s been a frustrating slide but expecting to see some decent progress on the Nasdaq and lots of positive news flow in the first couple of weeks.
It’s not far away now.
Well the constant downward pressure and the move to the Nasdaq has certainly flushed out quite a few holders. No doubt the delays have also contributed.
Good luck to them elsewhere, can’t blame them although I still believe that TILS day in the sun will come, that’s why I’m still here.
Still here. 96p average with 63,000 ACCU shares and 110,000 TILS.
A bit over leveraged but will sell a little on the way up.
No hurry though, the company is cashed up for the next 2-3 years.
Ok Shiraz, cheers for the explanation. I wasn’t digging you out but the Twitter comment didn’t correspond with what I had seen you post here previously. ATB
Shiraz, I notice on Twitter you claim to have made 300k profit on TILS last year?
On LSE you have always peddled the narrative that you were continuing to buy and had a high average..
Which is it?
I also notice on Twitter that Sporty has turned very bearish against TILS and GC after supposedly having a £500,000 holding at one point.